Target intelligence / Profile preview

Cellular RNA substrates susceptible to off-target adenine deamination by the TadA deaminase domain (RNA off-targets of ABE)

Target
RNA off-targets of ABE
Molecular classification
RNA, Transcriptome
01

Overview

Cellular RNA substrates susceptible to off-target adenine deamination refer to the vast array of RNA molecules unintentionally modified by Adenine Base Editors (ABEs). ABEs typically employ a laboratory-evolved TadA (tRNA-specific adenosine deaminase) domain from Escherichia coli, fused to a CRISPR-Cas protein, to perform targeted A-to-G transitions in genomic DNA (Gaudelli et al., 2017). However, studies have revealed that the TadA domain retains an inherent affinity for RNA, leading to extensive, guide-independent A-to-I (adenosine-to-inosine) deamination across the transcriptome (Grünewald et al., 2019; Rees et al., 2019). Because inosine is recognized as guanosine by the cellular translation machinery, these off-target events can result in the synthesis of synonymous or non-synonymous protein variants, potentially causing cellular toxicity or functional impairment. While RNA editing is transient and does not permanently alter the genome, the high frequency and breadth of these modifications present a significant safety hurdle for the clinical translation of base editing therapies. Consequently, next-generation ABEs are being engineered with specific mutations in the TadA domain to minimize RNA binding while maintaining high DNA editing efficiency.

Other names
Transcriptome-wide off-target RNA editingABE-induced RNA deaminationOff-target A-to-I RNA editingTadA-mediated RNA editingGuide-independent RNA editing
02

Mechanism of action

Hydrolytic deamination of adenosine to inosine in RNA transcripts, which is read as guanosine by the translation machinery.

03

Biological functions

Protein synthesisRNA processingGene expression regulation
04

Disease associations

Potential cellular toxicityIatrogenic phenotypic changesProteotoxicity
05

Safety considerations

Transcriptome-wide mutationsProduction of aberrant proteinsPotential for cellular toxicityUnpredictable phenotypic consequences in clinical gene editing
06

Interacting drugs

Adenine Base Editors (ABEs)

5 more in the full profile.

07

Biomarkers

A-to-I RNA editing levelsRNA-seq variant analysisInosine-specific cleavage assays

Beyond the preview

Go deeper on Cellular RNA substrates susceptible to off-target adenine deamination by the TadA deaminase domain (RNA off-targets of ABE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular RNA substrates susceptible to off-target adenine deamination by the TadA deaminase domain (RNA off-targets of ABE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call